Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients
Status:
Completed
Trial end date:
2018-10-11
Target enrollment:
Participant gender:
Summary
This is a Phase 1, Multicenter, Open-Label, Parallel Group Adaptive Pharmacokinetic Single
Dose Study of ISIS 681257 Subcutaneous Injections in Male And Female Subjects with Normal and
Impaired Renal Function